ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 702129 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 702129; 2) Community: the network communities that were significantly associated with the response to NSC 702129; 3) Molecule: the relationships between components within communities and NSC 702129; 4) MDR: the compounds that were significantly associated with the NSC 702129.

NSC Compound Enrichment Correlation
NSC 711077 Null 0.0474314077111082 -0.25491679
NSC 718630 Null 0.0474314077111082 0.20645883
NSC 718781 Erlotinib hydrochloride 0.0474314077111082 0.27147641
NSC 725098 Null 0.0474314077111082 -0.32801905
NSC 726217 Combretastatin A4-analogue 0.0474314077111082 -0.14870443
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0474314077111082 -0.14114951
NSC 740357 Null 0.0474314077111082 0.25483805
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0474314077111082 -0.11716883
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.0474314077111082 -0.23737962
NSC 752346 Null 0.0474314077111082 -0.054728563
Total:97  Current:92    [First] [Prev] [Next] [Last]